申请人:Adir et Compagnie
公开号:US05385930A1
公开(公告)日:1995-01-31
The invention relates to compounds of the formula I: ##STR1## in which R.sub.1 is as defined in the description, their optical isomers and their addition salts with a pharmaceutically-acceptable acid or base, and medicinal products which are useful for treating Central Nervous System disorders.
本发明涉及公式I的化合物:##STR1## 其中R.sub.1如描述中所定义,它们的光学异构体以及它们与药学上可接受的酸或碱的加成盐,以及用于治疗中枢神经系统疾病的药物产品。